Literature DB >> 6085009

Mechanism of alpha 2-macroglobulin-proteinase interactions. Studies with trypsin and plasmin.

U Christensen, L Sottrup-Jensen.   

Abstract

The time course of the interactions of alpha 2-macroglobulin with trypsin and with plasmin was studied by measuring the generation of thiol groups, the concentration of alpha 2-macroglobulin subunits cleaved at the bait regions, and the change in intrinsic protein fluorescence of alpha 2-macroglobulin-enzyme reaction mixtures as functions of time. The interaction of alpha 2-macroglobulin with trypsin was found to be very fast but could be studied in the presence of benzamidine, a rather strong competitive inhibitor of trypsin. The results obtained indicate that alpha 2-macroglobulin-proteinase reactions, known to involve specific limited proteolysis of the bait regions, gross conformational changes, and cleavage of the internal beta-cysteinyl-gamma-glutamyl thiol esters of native alpha 2-macroglobulin, may proceed via at least two different reaction pathways determined by the nature of or the concentration of the reacting proteinase. After initial cleavage of one bait region at high proteinase activity the next step presumably is a fast cleavage of a second bait region before any substantial rearrangements leading to generation of thiol groups and the final incorporation of the proteinase occur. At low proteinase activity no further bait region cleavages occur and only the two thiol groups of half of the alpha 2-macroglobulin molecule are generated in the final 1:1 complex.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085009     DOI: 10.1021/bi00321a052

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Novel complex formed between a nonproteolytic cell wall protein of group A streptococci and alpha 2-macroglobulin.

Authors:  G S Chhatwal; G Albohn; H Blobel
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

2.  Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes.

Authors:  Joseph M Mettenburg; Steven L Gonias
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

3.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

4.  Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Authors:  P K Anonick; S L Gonias
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Authors:  Lakshmi Venkatraman; Ser-Mien Chia; Balakrishnan Chakrapani Narmada; Jacob K White; Sourav S Bhowmick; C Forbes Dewey; Peter T So; Lisa Tucker-Kellogg; Hanry Yu
Journal:  Biophys J       Date:  2012-09-05       Impact factor: 4.033

6.  Kinetics of the reaction of thrombin and alpha 2-macroglobulin.

Authors:  R D Feinman; A I Yuan; S R Windwer; D Wang
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

7.  Design of a new protease inhibitor by the manipulation of the bait region of alpha 2-macroglobulin: inhibition of the tobacco etch virus protease by mutant alpha 2-macroglobulin.

Authors:  L Van Rompaey; P Proost; H Van den Berghe; P Marynen
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

Review 8.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

9.  Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.

Authors:  Piet Meijer; Michel Hanss; Ulla Christensen; Bjorn Wiman; Kees Kluft
Journal:  EJIFCC       Date:  2001-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.